Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTCy versus ATG for GVHD prophylaxis after reduced-intensity allogeneic peripheral blood stem cell transplantation
2016-002129-12Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2016
- Modality
- Small Molecules, Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of cyclophosphamide, antithymocyte globulin rabbit in graft-versus-host disease (GVHD), sponsored by Assistance publique - Hôpitaux de Paris. Started Nov 2016; status: completed.
02
Drugs
cyclophosphamideantithymocyte globulin rabbit
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on 2016-002129-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002129-12.